Suppr超能文献

口服给药途径纳米混悬液药物递送系统的剂型发展

Dosage Form Developments of Nanosuspension Drug Delivery System for Oral Administration Route.

作者信息

Chen Ang, Shi Ye, Yan Zhiqiang, Hao Hongxun, Zhang Yong, Zhong Jian, Hou Huiming

机构信息

College of Food Science & Technology, Shanghai Ocean University, Shanghai 201306, People's Republic of China.

出版信息

Curr Pharm Des. 2015;21(29):4355-65. doi: 10.2174/1381612821666150901105026.

Abstract

A large amount of new drug candidates are practically insoluble in aqueous solvents and are even simultaneously poorly soluble in organic solvents. Nanosuspension drug delivery system (DDS) was firstly developed in 1994 and has attracted more and more attention as a formation solution for the poorly soluble drugs. By nansizing the poorly soluble drugs, nanosuspensions have several outstanding advantages for drug delivery. Among many administration routes of drug delivery, oral administration is the most preferred route due to its advantages such as ease of ingestion, versatility to accommodate various types of drug candidates, low production cost, high safety, good patient compliance, and pain avoidance. Current marketed pharmaceutical nanosuspension DDS products are mostly for oral administration. This review is to systematically summarize the nanosuspension DDS dosage form developments of poorly soluble drugs for oral administration use.

摘要

大量的新药候选物实际上不溶于水性溶剂,甚至同时在有机溶剂中的溶解度也很差。纳米混悬液给药系统(DDS)于1994年首次开发,作为难溶性药物的一种制剂解决方案,越来越受到关注。通过将难溶性药物纳米化,纳米混悬液在药物递送方面具有几个突出的优点。在多种药物递送途径中,口服给药是最优选的途径,因为它具有易于摄取、能够适应各种类型的候选药物、生产成本低、安全性高、患者顺应性好以及避免疼痛等优点。目前市场上销售的药物纳米混悬液DDS产品大多用于口服给药。本综述旨在系统总结用于口服给药的难溶性药物的纳米混悬液DDS剂型的发展情况。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验